Merit Medical Systems (MMSI 2.29%), a medical device developer serving cardiovascular and endoscopy markets, reported results for its second quarter ended June 30, 2025, on July 30, 2025. The company posted GAAP revenue of $382.5 million, up 13.2% from the prior year and above the analyst consensus of $374.2 million (GAAP). Non-GAAP earnings per share (EPS) reached $1.01, beating the $0.85 estimate. Reported GAAP EPS, however, declined 11.6% to $0.54. The quarter showed solid broad-based growth, especially ...